Porton Biopharma Limited has executed an exclusive licence agreement for worldwide marketing, sales and distribution of Erwinaze/Erwinase to Clinigen Group plc
U.S. WorldMeds, LLC has divested Sloan Pharma, S.a.r.l, a wholly-owned subsidiary, to ZELNORM (tegaserod) and all its global rights to Alfasigma USA, Inc.